Key result
VERITAS study details initial procedural experience with a next-generation LAA occluder without clinical outcomes.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“Specifically, the more conformable distal lobe, inverted distal end screw, and modification of the stabilizing anchors with the additional row together achieved secure device implants without compromising surrounding tissue and structures, as reflected by the low rates of pericardial effusion and device embolization.”
“the procedural outcomes 'exceptional,' but noted that data on the device's efficacy at stroke reduction are not yet available. 'In the meantime,' he writes, 'the VERITAS study has taken the first step in its namesake, providing the truth that clinicians need to guide their patients toward freedom from both stroke and the burden of lifelong anticoagulation.'”
“In the meantime, the VERITAS study has taken the first step in its namesake, providing the truth that clinicians need to guide their patients toward freedom from both stroke and the burden of lifelong anticoagulation.”
Clinical study demonstrates the impact of operator experience during next-generation left atrial appendage occlusion, highlighting procedural learning curves.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Nair et al. (2026) studied this question. Procedural experience implanting a next-generation left atrial appendage occluder was evaluated in the VERITAS study, but specific clinical findings were not reported.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: